InflaRx (IFRX) Equity Ratio (2016 - 2026)

InflaRx has disclosed Equity Ratio across 11 years of filings, most recently posting 0.75 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.75, down 6.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.75 (down 6.84% YoY), and the FY2025 annual result was 0.75, down 6.84% from the prior year.
• Equity Ratio came in at 0.75 for Q1 2026 at InflaRx, roughly flat from 0.75 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.94 in Q2 2023 to a low of 0.7 in Q3 2025.
• The 5-year median for Equity Ratio is 0.85 (2023), against an average of 0.84.
• Across the five-year window, Equity Ratio rose 10.14% in 2023 and declined 15.01% in 2025, its largest moves.
• InflaRx's Equity Ratio stood at 0.86 in 2022, then slipped by 1.09% to 0.85 in 2023, then dropped by 5.33% to 0.81 in 2024, then slipped by 6.84% to 0.75 in 2025, then grew by 0.26% to 0.75 in 2026.
• The last three Equity Ratio figures came in at 0.75 (Q1 2026), 0.75 (Q4 2025), and 0.7 (Q3 2025), per Business Quant data.